Demo

Positive impact on lives and healthcare budgets.

Podimetrics is bringing new hope to patients, payors and providers. View our favorite highlights below or see all our clinical evidence.

Choose Evidence

Reduced Complications and Amputations

In a peer reviewed study, involving a year long foot ulcer recurrence prevention program at four outpatient centers, Podimetrics reduced:

0%
All diabetic amputations reduced by 71%1
0%
Severe DFUs reduced by 91%1
0%
All DFUs reduced by 46%1

Patient Experience and Adherence

In two different studies:

0%
75% Of patients remained
engaged at one year2
0%
88% of patients rated the
SmartMat “easy to use”3

Reduced Complications and Amputations

In a peer reviewed study, involving a year long foot ulcer recurrence prevention program at four outpatient centers, Podimetrics reduced:

0%
All-cause inpatient admissions:
52% relative risk reduction1
0%
Emergency department visits 40% relative risk reduction1
0%
All-cause outpatient admissions 26% relative risk reduction1
2
Two fewer podiatry outpatient visits per participant year during the treatment phase1

† Net difference was observed despite 1.6 additional podiatry outpatient visits per-participant year resulting from inflammation detected by the study device.

Cost Savings and ROI

Podimetrics calculates up to $13,000 in annual cost savings per patient4

3.6X – 5.2X

3.6X - 5.2X expected return on investment (ROI)1

$9,800 – 14,000

$9,800 - 14,000 expected annual cost savings per member5

How much could your organization save?

Contact Us

Choose innovation.
Not complications and amputations.

Learn More

What's new at Podimetrics?

All News

1. Isaac, et al. BMJ Open Diab Res Care 2020
2. Rothenberg, et al. Fed Pract. 2020
3. Frykberg, et al. Diabetes Care 2017
4. Podimetrics Data on File
5. Assumptions based on 90 weeks of Intermountain Health claims data for 428 at-risk patients and applying results from our recent peer-reviewed study with Kaiser Permanente in the British Journal of Medicine (BMJ)